{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T12:31:22Z","timestamp":1793017882939,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.critrevonc.2023.103992","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T11:44:11Z","timestamp":1681299851000},"page":"103992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Current status of locally advanced rectal cancer therapy and future prospects"],"prefix":"10.1016","volume":"186","author":[{"given":"Ioannis M.","family":"Koukourakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Kouloulias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Tiniakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Georgakopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zygogianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.critrevonc.2023.103992_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S1470-2045(15)00120-5","article-title":"High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study","volume":"16","author":"Appelt","year":"2015","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103992_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1470-2045(20)30555-6","volume":"22","author":"Bahadoer","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2023.103992_bib3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1148\/31.6.724","article-title":"Results of radiation therapy in primary operable rectal and anal cancer","volume":"31","author":"Binkley","year":"1938","journal-title":"Radiology"},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103992_bib4","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa060829","article-title":"Chemotherapy with preoperative radiotherapy in rectal cancer","volume":"355","author":"Bosset","year":"2006","journal-title":"N. Engl. J. Med"},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103992_bib5","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/annonc\/mdu560","article-title":"Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial","volume":"26","author":"Breugom","year":"2015","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103992_bib6","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S1470-2045(14)71199-4","article-title":"Adjuvant chemotherapy after preoperative (chemo)radiotherapy and surgery for patients with rectal cancer: a systematic review and meta-analysis of individual patient data","volume":"16","author":"Breugom","year":"2015","journal-title":"Lancet Oncol."},{"issue":"10","key":"10.1016\/j.critrevonc.2023.103992_bib7","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/bjs.5506","article-title":"Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer","volume":"93","author":"Bujko","year":"2006","journal-title":"Br. J. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103992_bib8","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/annonc\/mdw062","article-title":"Long-course oxaliplatin-based preoperative chemoradiation versus 5 \u00d7 5 Gy and consolidation chemotherapy for cT4 or fixed cT3 rectal cancer: results of a randomized phase III study","volume":"27","author":"Bujko","year":"2016","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103992_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ramb.2012.09.001","article-title":"The life and legacy of William Ernest Miles (1869-1947): a tribute to an admirable surgeon","volume":"59","author":"Campos","year":"2013","journal-title":"Rev. Assoc. Med Bras. (1992)"},{"issue":"14","key":"10.1016\/j.critrevonc.2023.103992_bib10","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1056\/NEJM199704033361402","article-title":"Improved survival with preoperative radiotherapy in resectable rectal cancer","volume":"336","author":"Cedermark","year":"1997","journal-title":"N. Engl. J. Med"},{"issue":"25","key":"10.1016\/j.critrevonc.2023.103992_bib11","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa2201445","article-title":"PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer","volume":"386","author":"Cercek","year":"2022","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103992_bib12","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1634\/theoncologist.2019-0437","volume":"25","author":"Chakravarthy","year":"2020","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103992_bib13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/00000658-194107000-00007","article-title":"Regional lymphatic metastases of carcinoma of the colon","volume":"114","author":"Coller","year":"1941","journal-title":"Ann. Surg."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103992_bib14","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S1470-2045(21)00079-6","article-title":"Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial","volume":"22","author":"Conroy","year":"2021","journal-title":"Lancet Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.ijrobp.2009.02.037","article-title":"Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer","volume":"76","author":"Crane","year":"2010","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"34","key":"10.1016\/j.critrevonc.2023.103992_bib16","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1200\/JCO.18.02309","article-title":"Neoadjuvant Modified FOLFOX6 With or Without Radiation Versus Fluorouracil Plus Radiation for Locally Advanced Rectal Cancer: Final Results of the Chinese FOWARC Trial","volume":"37","author":"Deng","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103992_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000005799","article-title":"Locoregional Failure During and After Short-course Radiotherapy followed by Chemotherapy and Surgery Compared to Long-course Chemoradiotherapy and Surgery - A Five-year Follow-up of the RAPIDO Trial","author":"Dijkstra","year":"2023","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00000658-194809000-00009","article-title":"Anterior resection for malignant lesions of the upper part of the rectum and lower part of the sigmoid","volume":"128","author":"Dixon","year":"1948","journal-title":"Ann. Surg."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103992_bib19","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.3390\/cancers14092252","article-title":"The Prognostic importance of ctDNA in Rectal Cancer: A Critical Reappraisal","volume":"14","author":"Dizdarevic","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103992_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2468-1253(17)30074-2","article-title":"A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysis","volume":"2","author":"Dossa","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.critrevonc.2023.103992_bib21","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.scrs.2010.01.002","article-title":"MD, FACS. The Natural History of Rectal Cancer 1908-2008: The Evolving Treatment of Rectal Cancer into the Twenty-First Century","volume":"21","author":"Enker","year":"2010","journal-title":"Semin Colon Rectal Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib22","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson","year":"2017","journal-title":"Lancet Oncol."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103992_bib23","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jamaoncol.2019.2294","article-title":"Effect of Aflibercept Plus Modified FOLFOX6 Induction Chemotherapy Before Standard Chemoradiotherapy and Surgery in Patients With High-Risk Rectal Adenocarcinoma: The GEMCAD 1402 Randomized Clinical Trial","volume":"5","author":"Fern\u00e1ndez-Martos","year":"2019","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00268-012-1862-z","article-title":"Neoadjuvant radiotherapy for rectal cancer: adherence to evidence-based guidelines in clinical practice","volume":"37","author":"Fitzgerald","year":"2013","journal-title":"World J. Surg."},{"issue":"34","key":"10.1016\/j.critrevonc.2023.103992_bib25","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO\/ARO\/AIO-12","volume":"37","author":"Fokas","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.critrevonc.2023.103992_bib26","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1200\/JCO.22.00032","article-title":"Organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy","volume":"40","author":"Garcia-Aguilar","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.critrevonc.2023.103992_bib27","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJM198506063122301","article-title":"Prolongation of the disease-free interval in surgically treated rectal carcinoma","volume":"312","author":"Gastrointestinal Tumor Study Group","year":"1985","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.critrevonc.2023.103992_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1200\/JCO.2022.40.4_suppl.099","article-title":"Phase II study of durvalumab following neoadjuvant chemoRT in operable rectal cancer: NSABP FR-2","volume":"40","author":"George","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103992_bib29","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1097\/00000658-198811000-00011","article-title":"Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC)","volume":"208","author":"G\u00e9rard","year":"1988","journal-title":"Ann. Surg."},{"issue":"28","key":"10.1016\/j.critrevonc.2023.103992_bib30","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1200\/JCO.2006.06.7629","article-title":"Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203","volume":"24","author":"G\u00e9rard","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103992_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/01.sla.0000141194.27992.32","article-title":"Operative versus non-operative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results","volume":"240","author":"Habr-Gama","year":"2004","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib32","first-page":"277","article-title":"A new approach to rectal cancer","volume":"22","author":"Heald","year":"1979","journal-title":"Br. J. Hosp. Med"},{"key":"10.1016\/j.critrevonc.2023.103992_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.01.026","article-title":"Circulating tumor DNA detection after neoadjuvant treatment and surgery predicts recurrence in patients with early-stage and locally advanced rectal cancer","author":"Hofste","year":"2023","journal-title":"Eur. J. Surg. Oncol."},{"issue":"33","key":"10.1016\/j.critrevonc.2023.103992_bib34","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1200\/JCO.19.00016","article-title":"Oxaliplatin-Based Adjuvant Chemotherapy for Rectal Cancer After Preoperative Chemoradiotherapy (ADORE): Long-Term Results of a Randomized Controlled Trial","volume":"37","author":"Hong","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103992_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/1097-0142(19850101)55:1<61::AID-CNCR2820550111>3.0.CO;2-Z","article-title":"Adjuvant postoperative radiotherapy in carcinoma of the rectum and rectosigmoid","volume":"55","author":"Hoskins","year":"1985","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103992_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1393133","article-title":"Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+\/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer","volume":"7","author":"Jarosch","year":"2017","journal-title":"Oncoimmunology"},{"issue":"15","key":"10.1016\/j.critrevonc.2023.103992_bib37","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1200\/JCO.21.01667","article-title":"Multicenter, Randomized, Phase III Trial of Short-Term Radiotherapy Plus Chemotherapy Versus Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer (STELLAR","volume":"40","author":"Jin","year":"2022","journal-title":"J. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2023.103992_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1056\/NEJMoa010580","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer","volume":"345","author":"Kapiteijn","year":"2001","journal-title":"N. Engl. J. Med"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188704","article-title":"Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles","volume":"1877","author":"Koukourakis","year":"2022","journal-title":"Biochim Biophys. Acta Rev. Cancer"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103992_bib40","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijrobp.2010.02.037","article-title":"Bevacizumab, capecitabine, amifostine, and preoperative hypofractionated accelerated radiotherapy (HypoArc) for rectal cancer: a Phase II study","volume":"80","author":"Koukourakis","year":"2011","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"11","key":"10.1016\/j.critrevonc.2023.103992_bib41","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003554","article-title":"Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer","volume":"9","author":"Lin","year":"2021","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib42","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/ijc.34302","article-title":"Patient-derived tumor organoids predict responses to irinotecan-based neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer","volume":"152","author":"Lv","year":"2023","journal-title":"Int J. Cancer"},{"issue":"35","key":"10.1016\/j.critrevonc.2023.103992_bib43","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1200\/JCO.2011.37.7176","article-title":"Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer","volume":"29","author":"Maas","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"8843","key":"10.1016\/j.critrevonc.2023.103992_bib44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0140-6736(93)90207-W","article-title":"Mesorectal excision for rectal cancer","volume":"341","author":"MacFarlane","year":"1993","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib45","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41416-022-01769-8","article-title":"Liquid biopsies to monitor and direct cancer treatment in colorectal cancer","volume":"127","author":"Mauri","year":"2022","journal-title":"Br. J. Cancer"},{"issue":"7572","key":"10.1016\/j.critrevonc.2023.103992_bib46","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1136\/bmj.38937.646400.55","article-title":"Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study","volume":"333","author":"MERCURY Study Group","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103992_bib47","first-page":"361","article-title":"A method of performing abdomino-perineal excision for carcinoma of the rectum and of the terminal portion of the pelvic colon (1908","volume":"21","author":"Miles","year":"1971","journal-title":"CA Cancer J. Clin."},{"issue":"31","key":"10.1016\/j.critrevonc.2023.103992_bib48","article-title":"Patient-derived organoids from colorectal cancer with paired liver metastasis reveal tumor heterogeneity and predict response to chemotherapy","volume":"9","author":"Mo","year":"2022","journal-title":"Adv. Sci. (Weinh. )"},{"key":"10.1016\/j.critrevonc.2023.103992_bib49","article-title":"Artificial Intelligence-Based Prediction of Recurrence after Curative Resection for Colorectal Cancer from Digital Pathological Images","author":"Nakanishi","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103992_bib50","unstructured":"NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae), 2023, Rectal Cancer, Version 4.2022. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/rectal.pdf (accessed 12 February 2023)."},{"issue":"31","key":"10.1016\/j.critrevonc.2023.103992_bib51","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1200\/JCO.2012.42.9597","article-title":"Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04","volume":"30","author":"Ngan","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib52","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/17474124.2021.1845141","article-title":"An update on the use of immunotherapy in patients with colorectal cancer","volume":"15","author":"Nguyen","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"issue":"513","key":"10.1016\/j.critrevonc.2023.103992_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med"},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103992_bib54","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/codi.15669","article-title":"Tailored total neoadjuvant therapy for locally advanced rectal cancer: One size may not fit for all","volume":"23","author":"Ozer","year":"2021","journal-title":"Colorectal Dis."},{"issue":"12","key":"10.1016\/j.critrevonc.2023.103992_bib55","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.3390\/cancers12123611","article-title":"Neoadjuvant chemotherapy in locally advanced rectal cancer","volume":"12","author":"Papaccio","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103992_bib56","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1634\/theoncologist.2017-0484","article-title":"Phase II Study of Preoperative Treatment with External Radiotherapy Plus Panitumumab in Low-Risk, Locally Advanced Rectal Cancer (RaP Study\/STAR-03","volume":"23","author":"Pinto","year":"2018","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103992_bib57","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1470-2045(15)00467-2","article-title":"Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis","volume":"17","author":"Renehan","year":"2016","journal-title":"Lancet Oncol."},{"issue":"8","key":"10.1016\/j.critrevonc.2023.103992_bib58","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S1470-2045(15)00159-X","article-title":"Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO\/ARO\/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial","volume":"16","author":"R\u00f6del","year":"2015","journal-title":"Lancet Oncol."},{"issue":"31","key":"10.1016\/j.critrevonc.2023.103992_bib59","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.103992_bib60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.ctrv.2018.01.001","article-title":"The role of chemotherapy in localized and locally advanced rectal cancer: A systematic revision","volume":"63","author":"Rosell\u00f3","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2023.103992_bib61","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12885-015-1053-z","article-title":"A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features","volume":"15","author":"Salazar","year":"2015","journal-title":"BMC Cancer"},{"issue":"17","key":"10.1016\/j.critrevonc.2023.103992_bib62","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer","year":"2004","journal-title":"N. Engl. J. Med"},{"issue":"9666","key":"10.1016\/j.critrevonc.2023.103992_bib63","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0140-6736(09)60484-0","article-title":"Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial","volume":"373","author":"Sebag-Montefiore","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103992_bib64","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13014-020-01673-6","article-title":"Efficacy and safety-in analysis of short-course radiation followed by mFOLFOX-6 plus avelumab for locally advanced rectal adenocarcinoma","volume":"15","author":"Shamseddine","year":"2020","journal-title":"Radiat. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103992_bib65","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2023.103992_bib66","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrclinonc.2017.14","article-title":"Integrating liquid biopsies into the management of cancer","volume":"14","author":"Siravegna","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103992_bib67","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.5896","article-title":"Assessment of a watch-and-wait strategy for rectal cancer in patients with a complete response after neoadjuvant therapy","volume":"5","author":"Smith","year":"2019","journal-title":"JAMA Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib68","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00384-022-04096-9","article-title":"Oxaliplatin-based adjuvant chemotherapy rather than fluorouracil-based chemotherapy in rectal cancer is more efficient to decrease distant metastasis and increase survival after preoperative chemoradiotherapy and surgery: a meta-analysis","volume":"37","author":"Song","year":"2022","journal-title":"Int J. Colorectal Dis."},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib69","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic Immunity Is Required for Effective Cancer Immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2023.103992_bib70","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2023.103992_bib71","first-page":"152","article-title":"Cancer of rectum; excision after application of radium","volume":"7","author":"Symonds","year":"1914","journal-title":"Proc. R. Soc. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2023.103992_bib72","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1200\/JCO.2012.45.3258","volume":"32","author":"Taylor","year":"2014","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2023.103992_bib73","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0167-8140(88)90219-8","article-title":"Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience","volume":"13","author":"Thomas","year":"1988","journal-title":"Radio. Oncol."},{"issue":"2","key":"10.1016\/j.critrevonc.2023.103992_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212978","article-title":"Clinical significance of soluble programmed cell death-1 and soluble programmed cell death-ligand 1 in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy","volume":"14","author":"Tominaga","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.critrevonc.2023.103992_bib75","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1470-2045(11)70097-3","article-title":"Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial","volume":"12","author":"van Gijn","year":"2011","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2023.103992_bib76","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0360-3016(87)90037-X","article-title":"Postoperative adjuvant radiotherapy for adenocarcinoma of the rectum and rectosigmoid","volume":"13","author":"Vigliotti","year":"1987","journal-title":"Int J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.critrevonc.2023.103992_bib77","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/jnci\/92.5.388","article-title":"Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02","volume":"92","author":"Wolmark","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2023.103992_bib78","doi-asserted-by":"crossref","DOI":"10.1007\/s12029-022-00906-z","article-title":"A Review of Circulating Tumor DNA as a Biomarker Guide for Total Neoadjuvant Therapy in Patients with Locally Advanced Rectal Cancer","author":"Yahya","year":"2023","journal-title":"J. Gastrointest. Cancer"},{"key":"10.1016\/j.critrevonc.2023.103992_bib79","doi-asserted-by":"crossref","first-page":"1061388","DOI":"10.3389\/fimmu.2022.1061388","article-title":"Cancer organoid co-culture model system: Novel approach to guide precision medicine","volume":"13","author":"Yuan","year":"2023","journal-title":"Front Immunol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282300080X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282300080X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:48:37Z","timestamp":1760903317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282300080X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":79,"alternative-id":["S104084282300080X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103992","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current status of locally advanced rectal cancer therapy and future prospects","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103992","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103992"}}